Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy

Gynecologic Oncology

Volumn 140, Issue 1, 2016, Pages 95-100

  Tucker, Paige E ^a,b   Bulsara, Max K ^b   Salfinger, Stuart G ^a   Tan, Jason Jit Sun ^a   Green, Helena ^c   Cohen, Paul A ^a  

^a St John of God Subiaco Hospital   (Australia)

^b UNIVERSITY OF NOTRE DAME   (Australia)

^c Women Centre   (Australia)

Author keywords

Androgen levels; BRCA1; BRCA2; Breast cancer; Female sexual dysfunction; Female sexual function; Hypoactive sexual desire disorder; Lynch syndrome; Ovarian cancer; Prophylactic oophorectomy; Risk reducing salpingo oophorectomy

Indexed keywords

ANDROGEN; AROMATASE INHIBITOR; ESTROGEN; GOSERELIN; TESTOSTERONE;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY IMAGE; BREAST CANCER; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISTRESS SYNDROME; DYSPAREUNIA; FEMALE; FEMALE SEXUAL DYSFUNCTION; GENERALIZED BODY PAIN; HORMONE SUBSTITUTION; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; HYSTERECTOMY; LUBRICATION; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MENOPAUSE; MIDDLE AGED; ORGASM DISORDER; OUTCOME ASSESSMENT; PAIN; PERSONAL EXPERIENCE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK REDUCING SALPINGOOOPHORECTOMY; SALPINGOOOPHORECTOMY; SEXUAL DISTRESS; SEXUAL FUNCTION; SEXUAL SATISFACTION; SEXUALITY; TERTIARY CARE CENTER; TESTOSTERONE BLOOD LEVEL; TIME TO TREATMENT; ADVERSE EFFECTS; AGED; BLOOD; GENITAL NEOPLASMS, FEMALE; OVARIECTOMY; PROCEDURES; SALPINGECTOMY; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

ADULT; AGED; ANDROGENS; CROSS-SECTIONAL STUDIES; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; OVARIECTOMY; PREVALENCE; SALPINGECTOMY; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTOSTERONE;

EID: 84952636747     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.11.002     Document Type: Article

References (39)

1. ACOG Practice bulletin no. 89. Elective and risk-reducing salpingo-oophorectomy Obstet. Gynecol. 111 2008 231 241
2. J.S. Kwon, A. Tinker, G. Pansegrau, J. McAlpine, M. Housty, M. McCullum, and et al. Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers Obstet. Gynecol. 121 2013 14 24
3. L. Elit, M.J. Esplen, K. Butler, and S. Narod Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer Familial Cancer 1 2001 149 156
4. A. Fry, C. Busby-Earle, R. Rush, and A. Cull Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer Psycho-Oncology 10 2001 231 241
5. M. Robson, M. Hensley, R. Barakat, C. Brown, D. Chi, E. Poynor, and et al. Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy Gynecol. Oncol. 89 2003 281 287
6. I. van Oostrom, H. Meijers Heijboer, L. Lodder, H. Duivenvoorden, A. van Gool, C. Seynaeve, and et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study J. Clin. Oncol. 21 2003 3867 3874
7. J.B. Madalinska, J. Hollenstein, E. Bleiker, M. van Beurden, H.B. Valdimarsdottir, L.F. Massuger, and et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer J. Clin. Oncol. 23 2005 6890 6898
8. J.B. Madalinska, M. van Beurden, E.M. Bleiker, H.B. Valdimarsdottir, J. Hollenstein, L.F. Massuger, and et al. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy J. Clin. Oncol. 24 2006 3576 3582
9. C.Y. Fang, C. Cherry, K. Devarajan, T. Li, J. Malick, and M.B. Daly A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer Gynecol. Oncol. 112 2009 594 600
10. D. Campfield Bonadies, A. Moyer, and E.T. Matloff What I wish I'd known before surgery: BRCA carriers' perspectives after bilateral salipingo-oophorectomy Familial Cancer 10 2011 79 85
11. A. Finch, K.A. Metcalfe, J.K. Chiang, L. Elit, J. McLaughlin, C. Springate, and et al. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation Gynecol. Oncol. 121 2011 163 168
12. L. Brotto, N. Branco, C. Dunkley, M. McCullum, and J. McAlpine Risk-reducing bilateral salpingo-oophorectomy and sexual health: a qualitative study JOGC. 34 2012 172 178
13. T. Lorenz, B. McGregor, and E. Swisher Relationship satisfaction predicts sexual activity following risk-reducing salpingo-oophorectomy J. Psychosom. Obstet. Gynaecol. 35 2014 62 68
14. E.T. Matloff, R.E. Barnett, and S.L. Bober Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers Cancer J. 15 2009 15 18
15. N. Hallowell You dont want to lose your ovaries because you think "I might become a man". Women's perceptions of prophylactic surgery as a cancer risk management option Psychooncology 7 1998 263 275
16. J.L. Shifren, G.D. Braunstein, J.A. Simon, P.R. Casson, J.E. Buster, G.P. Redmond, and et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy N. Engl. J. Med. 343 2000 682 688
17. G.D. Braunstein, D.A. Sundwall, M. Katz, J.L. Shifren, J.E. Buster, J.A. Simon, and et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women Arch. Intern. Med. 165 2005 1582 1589
18. S.R. Davis, S.L. Davison, S. Donath, and R.J. Bell Circulating androgen levels and self-reported sexual function in women J. Am. Med. Assoc. 294 2005 91 96
19. S. Wahlin-Jacobsen, A.T. Pedersen, E. Kristensen, N.C. Laessoe, M. Lundqvist, A.S. Cohen, and et al. Is there a correlation between androgens and sexual desire in women? J Sex Med. 12 2015 358 373
20. R. Rosen, C. Brown, J. Heiman, S. Leiblum, C. Meston, R. Shabsigh, and et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function J Sex Marital Ther. 26 2000 191 208
21. M. Wiegel, C. Meston, and R. Rosen The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores J Sex Marital Ther. 31 2005 1 20
22. E.P. Gerstenberger, R.C. Rosen, J.V. Brewer, C.M. Meston, L.A. Brotto, M. Wiegel, and et al. Sexual desire and the female sexual function index (FSFI): a sexual desire cutpoint for clinical interpretation of the FSFI in women with and without hypoactive sexual desire disorder J Sex Med. 7 2010 3096 3103
23. K. Thirlaway, L. Fallowfield, and J. Cuzick The sexual activity questionnaire: a measure of women's sexual functioning 5 1996 81 90
24. L. Derogatis, A. Clayton, D. Lewis-D'Agostino, G. Wunderlich, and Y. Fu Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder J Sex Med. 5 2008 357 364
25. S. Hendrick A generic measure of relationship satisfaction J Marriage Fam. 50 1988 93 98
26. M. Wiederman Women's body image self-consciousness during physical intimacy with a partner J Sex Res. 37 2000 60 68
27. J.R. Hilditch, J. Lewis, A. Peter, B. van Maris, A. Ross, E. Franssen, and et al. A menopause-specific quality of life questionnaire: development and psychometric properties Maturitas 61 2008 107 121
28. J. Ware, and C. Sherbourne The MOS 36-item short-form health survey (SF-36) Med. Care 30 1992 473 483
29. M. Horowitz, N. Wilner, and M. Alvarez Impact of event scale: a measure of subjective stress Psychosom. Med. 41 1979 209 218
30. S. Lemeshow, D.W. Hosmer Jr., J. Klar, and S.K. Lwanga Adequacy of Sample Size in Health Studies. Chichester [England]: Published on behalf of the World Health Organization by Wiley 1990
31. R.W. Lewis, K.S. Fugl-Meyer, R. Bosch, A.R. Fugl-Meyer, E.O. Laumann, E. Lizza, and et al. Epidemiology/risk factors of sexual dysfunction J Sex Med. 1 2004 35 39
32. E.O. Laumann, A. Paik, and R. Rosen Sexual dysfunction in the United States: prevalence and predictors J. Am. Med. Assoc. 281 1999 537 544
33. S.R. Leiblum, P.E. Koochaki, C.A. Rodenberg, I.P. Barton, and R.C. Rosen Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS) Menopause 13 2006 46 56
34. H.F.L. Meyer-Bahlburg, and C. Dolezal The female sexual function index: a methodological critique and suggestions for improvement J Sex Marital Ther. 33 2007 217 224
35. E.O. Laumann, A. Nicolosi, D.B. Glasser, A. Paik, C. Gingell, E. Moreira, and et al. Sexual problems among women and men aged 40-80y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviours Int. J. Impot. Res. 17 2005 39 57
36. A. Burri, G. Lachance, and F.M. Williams Prevalence and risk factors of sexual problems and sexual distress in a sample of women suffering from chronic widespread pain J Sex Med. 11 2014 2772 2784
37. M. Mollaoglu, F.O. Tuncay, and T.K. Fertelli Investigating the sexual function and its associated factors in women with chronic illnesses J. Clin. Nurs. 22 2013 3484 3491
38. M.A. Ellstrom Engh, K. Jerhamre, and K. Junskog A randomized trial comparing changes in sexual health and psychological well-being after subtotal and total hysterectomies Acta Obstet. Gynecol. Scand. 89 2010 65 70
39. J.F. Randolph Jr., H. Zheng, N.E. Avis, G.A. Greendale, and S.D. Harlow Masturbation frequency and sexual function domains are associated with serum reproductive hormone levels across the menopausal transition J. Clin. Endocrinol. Metab. 100 2015 258 266